IBA joins PFAROS European initiative to advance PFAS destruction for healthcare and pharmaceutical applications

Louvain-la-Neuve, Belgium, 2 September 2026, 7 a.m.  – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, today announces its participation in PFAROS, a new European research and innovation initiative launched to address environmental emissions and exposure concerns related to per- and polyfluoroalkyl substances (PFAS) in the pharmaceutical and medical sectors. As part of the project, IBA will co-lead the work on end-of-life and waste-management technologies, bringing its electron beam and Rhodotron® expertise to the assessment of PFAS destruction solutions.